Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Austin, Eric D ^a   Phillips, John A ^a   Cogan, Joy D ^a   Hamid, Rizwan ^a   Yu, Chang ^a   Stanton, Krista C ^a   Phillips, Charles A ^a   Wheeler, Lisa A ^a   Robbins, Ivan M ^a   Newman, John H ^a   Loyd, James E ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BMPR2 PROTEIN, HUMAN;

ADULT; ARTICLE; DISEASE SEVERITY; EXON; FEMALE; HETEROZYGOTE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MORTALITY; PHENOTYPE; PULMONARY HYPERTENSION; RNA ANALYSIS; SEX DIFFERENCE; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; INCIDENCE; MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; MALE; MUTATION; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TENNESSEE;

EID: 77955069395     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-87     Document Type: Article

References (39)

1. Runo JR, Loyd JE. Primary pulmonary hypertension. The Lancet 2003, 361(9368):1533-1544.
2. Machado R, Chung W, Eickelberg O, Elliot G, Hanaoka M, Geraci M, Loyd J, Newman J, Phillips J, Soubrier F, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2009,
3. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004, 43(12 Suppl S):5S-12S. 10.1016/j.jacc.2004.02.037, 15194173.
4. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000, 67(3):737-744. 10.1086/303059, 1287532, 10903931.
5. Lane KB, Blackwell TR, Runo J, Wheeler L, Phillips JA, Loyd JE. Aberrant signal transduction in pulmonary hypertension. Chest 2005, 128(6 Suppl):564S-565S. 10.1378/chest.128.6_suppl.564S-a, 16373826.
6. Newman JH, Wheeler L, Lane KB, Loyd E, Gaddipati R, Phillips JA, Loyd JE. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 2001, 345(5):319-324. 10.1056/NEJM200108023450502, 11484688.
7. Newman JH, Phillips JA, Loyd JE. Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies. Ann Intern Med 2008, 148(4):278-283.
8. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998, 352(9129):719-725. 10.1016/S0140-6736(98)02111-4, 9729004.
9. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987, 107(2):216-223.
10. Elliott CG, Glissmeyer EW, Havlena GT, Carlquist J, McKinney JT, Rich S, McGoon MD, Scholand MB, Kim M, Jensen RL, et al. Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension. Circulation 2006, 113(21):2509-2515. 10.1161/CIRCULATIONAHA.105.601930, 16717148.
11. Rosenzweig EB, Morse JH, Knowles JA, Chada KK, Khan AM, Roberts KE, McElroy JJ, Juskiw NK, Mallory NC, Rich S, et al. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J Heart Lung Transplant 2008, 27(6):668-674. 10.1016/j.healun.2008.02.009, 18503968.
12. Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, et al. Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation. Am J Respir Crit Care Med 2008,
13. Sztrymf B, Yaici A, Girerd B, Humbert M. Genes and pulmonary arterial hypertension. Respiration 2007, 74(2):123-132. 10.1159/000098818, 17318011.
14. Neu-Yilik G, Kulozik AE. NMD: multitasking between mRNA surveillance and modulation of gene expression. Adv Genet 2008, 62:185-243. full_text, 19010255.
15. Noensie EN, Dietz HC. A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat Biotechnol 2001, 19(5):434-439. 10.1038/88099, 11329012.
16. Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 2006, 14(10):1074-1081. 10.1038/sj.ejhg.5201649, 16757948.
17. Boyle MP. Strategies for identifying modifier genes in cystic fibrosis. Proc Am Thorac Soc 2007, 4(1):52-57. 10.1513/pats.200605-129JG, 2647615, 17202292.
18. Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 1984, 129(1):194-197.
19. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, Loyd JE. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004, 126(1 Suppl):14S-34S. 10.1378/chest.126.1_suppl.14S, 15249493.
20. Cogan JD, Pauciulo MW, Batchman AP, Prince MA, Robbins IM, Hedges LK, Stanton KC, Wheeler LA, Phillips Iii JA, Loyd JE, et al. High Frequency of BMPR2 Exonic Deletions/Duplications in Familial Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2006, 2648061, 16728714.
21. Cogan JD, Vnencak-Jones CL, Phillips JA, Lane KB, Wheeler LA, Robbins IM, Garrison G, Hedges LK, Loyd JE. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med 2005, 7(3):169-174.
22. Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, et al. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 2006, 27(2):121-132. 10.1002/humu.20285, 16429395.
23. Aldred MA, Machado RD, James V, Morrell NW, Trembath RC. Characterization of the BMPR2 5'-untranslated Region and a Novel Mutation in Pulmonary Hypertension. Am J Respir Crit Care Med 2007,
24. Said SI. Mediators and modulators of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2006,
25. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004, 351(14):1425-1436. 10.1056/NEJMra040291, 15459304.
26. Montani D, Souza R, Binkert C, Fischli W, Simonneau G, Clozel M, Humbert M. Endothelin-1/endothelin-3 ratio: a potential prognostic factor of pulmonary arterial hypertension. Chest 2007, 131(1):101-108. 10.1378/chest.06-0682, 17218562.
27. Krasnov KV, Tzetis M, Cheng J, Guggino WB, Cutting GR. Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships. Hum Mutat 2008, 29(11):1364-1372. 10.1002/humu.20866, 18951463.
28. Rudarakanchana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, Morrell NW. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 2002, 11(13):1517-1525. 10.1093/hmg/11.13.1517, 12045205.
29. Nishihara A, Watabe T, Imamura T, Miyazono K. Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. Mol Biol Cell 2002, 13(9):3055-3063. 10.1091/mbc.E02-02-0063, 124142, 12221115.
30. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54(1 Suppl):S20-31. 10.1016/j.jacc.2009.04.018, 19555855.
31. Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA, Newman J, Williams D, Galie N, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 2001, 68(1):92-102. 10.1086/316947, 1234937, 11115378.
32. Hamid R, Cogan JD, Hedges LK, Austin E, Phillips JA, Newman JH, Loyd JE. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele. Hum Mutat 2009, 30(4):649-654. 10.1002/humu.20922, 19206171.
33. Nasim MT, Ghouri A, Patel B, James V, Rudarakanchana N, Morrell NW, Trembath RC. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension. Hum Mol Genet 2008, 17(11):1683-1694. 10.1093/hmg/ddn059, 18321866.
34. Sobolewski A, Rudarakanchana N, Upton PD, Yang J, Crilley TK, Trembath RC, Morrell NW. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. Hum Mol Genet 2008, 17(20):3180-3190. 10.1093/hmg/ddn214, 18647753.
35. Kuzmiak HA, Maquat LE. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges. Trends Mol Med 2006, 12(7):306-316. 10.1016/j.molmed.2006.05.005, 16782405.
36. Shariat N, Ryther RC, Phillips JA, Robinson IC, Patton JG. Rescue of Pituitary Function in a Mouse Model of Isolated Growth Hormone Deficiency Type II by RNA Interference. Endocrinology 2008, 149(2):580-586. 10.1210/en.2007-1360, 2219309, 18006625.
37. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006, 173(9):1023-1030. 10.1164/rccm.200510-1668OC, 16456139.
38. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009, 135(3):794-804. 10.1378/chest.08-0492, 19265089.
39. Sitbon O, Humbert M, Jais X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Herve P, Simonneau G. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005, 111(23):3105-3111. 10.1161/CIRCULATIONAHA.104.488486, 15939821.